Biotech Values

[biomaven0]

Also, Dr. Ron Garren has pointed out that the T315I mutation is found in solid tumor cancers as well as hematological cancers and may have efficacy there as well.

Usually Garren is good, but this makes no sense to me. Even if it's true, it would be a tiny opportunity.
PH+ ALL makes sense though.

Don't disagree with the rest of your post.

Peter